¼¿ï¼º¸ðº´¿ø ½ÅÀåÀÌ½Ä 3,000·Ê ±â³ä ´ëÇÑÀ̽ÄÇÐȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2018-09-15 ±³À°ÀÏÀÚ : 2018-09-15
±³À°Àå¼Ò : ¼¿ï¼º¸ðº´¿ø ÁöÇÏ1Ãþ ´ë°´ç
±³À°ÁÖÁ¦ :
¼¿ï¼º¸ðº´¿ø ½ÅÀåÀÌ½Ä 3,000·Ê ±â³ä ´ëÇÑÀ̽ÄÇÐȸ °øµ¿ ½ÉÆ÷Áö¾ö ÁÖÃÖ±â°ü : ´ëÇÑÀ̽ÄÇÐȸ
´ã´çÀÚ : ½É¹Î°æ
¿¬¶ôó : 02-484-8052
À̸ÞÀÏ :
mykst@mykst.org ±³À°Á¾·ù : ³»°ú, ¿Ü°úÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09¿ù 15ÀÏ ´ë°´ç 08:30~12:00 µî·Ï ()
±âŸ 09¿ù 15ÀÏ ´ë°´ç 09:00~09:10 Àλ縻¹×Ãà»ç ¹®Á¤ÀÏ(°¡Å縯ÀÇ·á¿øÀå)
±âŸ 09¿ù 15ÀÏ ´ë°´ç 09:00~09:10 Àλ縻¹×Ãà»ç ±è¿ë½Ä(¼¿ï¼º¸ðº´¿øÀå)
±âŸ 09¿ù 15ÀÏ ´ë°´ç 09:00~09:10 Àλ縻¹×Ãà»ç ¹®Àμº(´ëÇÑÀ̽ÄÇÐȸȸÀå)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 09:10~09:25 Report of 3,000 cases ¹Ú¼øö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 09:25~09:40 How did we reach 3000 kidney transplants? ¾çö¿ì(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 09:40~10:00 Impact of ABOi-KT on living donor KT ±è¹ÌÇü(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 10:00~10:20 ABOi-KT as retransplantation À±ÇýÀº(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 10:20~10:40 Combined ABO and HLA incompatible KT ±èÂù´ö(°æºÏÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 10:40~11:00 ABOi-KT vs. exchanged donor program Çã±ÔÇÏ(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 09¿ù 15ÀÏ ´ë°´ç 11:00~11:20 Coffee break ()
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 11:20~11:40 Experimental transplantation of kidney organoids ±è¿ë±Õ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 11:40~12:00 Current status and perspective of exosome study ±è¼¼ÁØ(°¡Å縯ÀÇ´ë)
½Ä»ç 09¿ù 15ÀÏ ´ë°´ç 12:00~13:00 LUNCH ()
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 13:00~13:20 Old donor and recipients ±è¿µ¼ö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 13:20~13:40 Laparoscopic donor nephrectomy Á¶ÇõÁø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 13:40~14:00 Multivisceral transplantation ȲÁ¤±â(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 14:00~14:20 Clinical outcome of deceased donor with AKI ¹ÚÀç¹ü(¼º±Õ°üÀÇ´ë)
ÈÞ½Ä 09¿ù 15ÀÏ ´ë°´ç 14:20~14:40 Coffee Break ()
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 14:40~15:00 Detection of DSA ¿ÀÀºÁö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 15:00~15:20 Transition of pathologic diagnosis of ABMR ÃÖ¿µÁø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 15:20~15:40 Desensitization for living and deceased donor HLAi-KT ¾çÀç¼®(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 15:40~16:00 Management of chronic AMR ¹ÝÅÂÇö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 16:00~16:20 Management of invasive fungal infection ±è»óÀÏ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 16:20~16:40 Latent Tbc in kidney transplantation ±èÈ¿»ó(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 16:40~17:00 CTL therapy for EBV-associated lymphoma Á¶¼®±¸(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09¿ù 15ÀÏ ´ë°´ç 17:00~17:20 Prophylaxis of CMV infection °íÀºÁ¤(°¡Å縯ÀÇ´ë)
±âŸ 09¿ù 15ÀÏ ´ë°´ç 17:20~17:25 Closing ()
±âŸ 09¿ù 15ÀÏ ´ë°´ç 17:25~17:30 Ceremony of 3,000 kidney transplantation ()